HomeBGLC • NASDAQ
add
BioNexus Gene Lab Corp
Previous close
$0.57
Day range
$0.56 - $0.59
Year range
$0.31 - $17.89
Market cap
10.22M USD
Avg Volume
199.82K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 2.27M | -19.95% |
Operating expense | 99.38K | -74.60% |
Net income | 308.46K | 296.51% |
Net profit margin | 13.57 | 345.39% |
Earnings per share | — | — |
EBITDA | 187.28K | 787.49% |
Effective tax rate | -21.65% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 5.93M | 179.84% |
Total assets | 11.40M | 30.43% |
Total liabilities | 1.74M | -16.06% |
Total equity | 9.66M | — |
Shares outstanding | 17.67M | — |
Price to book | 1.04 | — |
Return on assets | 3.66% | — |
Return on capital | 4.26% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | 308.46K | 296.51% |
Cash from operations | -261.91K | -154.94% |
Cash from investing | -13.75K | 72.44% |
Cash from financing | 11.12K | 589.05% |
Net change in cash | -217.55K | -133.13% |
Free cash flow | 19.00K | -97.21% |
About
Founded
2017
Website
Employees
30